Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-25

Clinical Trial Update: Trial Testing Ftorafur (UFT) Associated With Neoadjuvant Radiotherapy Versus Radiotherapy Alone in Rectal Adenocarcinoma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing neoadjuvant radiotherapy with ftorafur (UFT) versus radiotherapy alone in rectal adenocarcinoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ftorafur (UFT) (ftorafur (UFT))

Snippet

Sponsor: Institut Cancerologie de l'Ouest | Conditions: Rectal Cancer, Stage II/III | Phase 3 | Status: TERMINATED